The journey of bringing bio-based technologies from the lab to the market is anything but easy, and having a trusted guide can make all the difference.? ???? ?????? ???????????????? ???? ???????????????? ?????? ???????????????? ???? ???????? ?????? ?????????????? ???????????????? ???? ?????? ????????! These industry experts will support Breakout, our portfolio, and our broader ecosystem — from diligencing investment opportunities to commercializing new tech. ???????????? ???????? ???? ???? ??????????????????: ? Sridhar Iyengar, PhD: Founder and Chief Strategy Officer of Elemental Machines ? Coco Krumme, PhD: Founder of Leeward Co ? Rebecca Nugent, PhD: VP of HTP Operations at Tessera Therapeutics ? Walter Solomon: Board Director and Advisor ? Ilan Zipkin, PhD: Founder and CEO of Supercede Therapeutics, Inc. Breakout Ventures is built on the theory that creative bioscience founders need more than just capital to take on the world's biggest challenges in human health and sustainability. Thank you to our venture partners, advisors, and community members for helping us build a bio-based future! ???????? ?????? ???????? ??????????????: https://lnkd.in/gp4SADTe
关于我们
Breakout Ventures is the home for creative bioscience entrepreneurs. We invest in early stage companies harnessing the power of cells to build solutions in human health and sustainability. Our team has spent the last decade supporting science-driven companies moving with urgency. We partner with bold founders throughout the entire life cycle, from seed to scale. Our portfolio has grown leather without the cow, reprogrammed B cells to produce personalized protein therapeutics, and transformed industrial carbon dioxide emissions into useful products. We believe cells are the engine of the next decade as the tools, technologies and, most importantly, talent from across industries are brought to bear on biology and chemistry in surprising ways. Breakout Ventures, building the future powered by science.
- 网站
-
https://www.breakout.vc
Breakout Ventures的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 2-10 人
- 总部
- San Francisco
- 类型
- 合营企业
- 创立
- 2016
- 领域
- Technology、Science、Deep Technology、Therapeutics、Sustainability、Human Health、Diagnostics、Biomanufacturing、Materials、Decarbonization、Cell Engineering、Neuro、Biomaterials、Waste Conversion、biochemicals、Genomics、Proteomics、Gene Therapy、Cell Therapy、Petroleum product replacement和
地点
-
主要
获取路线
US，San Francisco
Breakout Ventures员工
动态
-
After attending Magnify in 2022 and 2023 as a community member, I can hardly believe that I got to help put on this year's event as part of the Breakout Ventures team. From selecting speakers to forming the invite list to creating the content, hosting our annual event is quite the undertaking. It all paid off seeing this community come together to talk about the passion that powers us: turning science into solutions. Putting together this little post of our favorite photos and videos from the event made my heart so happy. I hope it brings a smile to your face, too. Thank you to Lindy Morris Fishburne, Julia Moore, Renée Shenton, Nima Ronaghi, PhD, Dana Watt, PhD, James Chan, CPA, and Ziv Yoash for welcoming me into the team in January! Can't believe we are already coming up on a year. Anywho, Happy Thanksgiving Week to all who celebrate. Cheers to being grateful for where we are and where we're going... and the people who stand beside us along the way.
In this season of gratitude, we are most thankful for... ??????! We're continually inspired by this community of unstoppable founders, investors and co-conspirators who are building a future powered by science. Our annual Magnify event gathers together a few hundred of our favorite people to dive into our ecosystem's most pressing questions and celebrate our collective accomplishments. This year, we debated how AI will reshape and reform the drug development funnel, bringing new medicines from discovery to the patients who need them faster and safer than ever before. A special thank you to our debaters: David Younger of A-Alpha Bio, Ron Alfa, MD, PhD of NOETIK, Karen Akinsanya of Schr?dinger, and Etai Jacob of AstraZeneca. Thank you to everyone who made this year's Magnify such a success. Check out the photos to see if you spot yourself and your friends! https://lnkd.in/dh4u-MrH
Celebrating Conversation and Community
medium.com
-
In this season of gratitude, we are most thankful for... ??????! We're continually inspired by this community of unstoppable founders, investors and co-conspirators who are building a future powered by science. Our annual Magnify event gathers together a few hundred of our favorite people to dive into our ecosystem's most pressing questions and celebrate our collective accomplishments. This year, we debated how AI will reshape and reform the drug development funnel, bringing new medicines from discovery to the patients who need them faster and safer than ever before. A special thank you to our debaters: David Younger of A-Alpha Bio, Ron Alfa, MD, PhD of NOETIK, Karen Akinsanya of Schr?dinger, and Etai Jacob of AstraZeneca. Thank you to everyone who made this year's Magnify such a success. Check out the photos to see if you spot yourself and your friends! https://lnkd.in/dh4u-MrH
Celebrating Conversation and Community
medium.com
-
A great change of pace to fly out to San Francisco to talk biotech innovation for Magnify! The better of part of the last two years with the folks on the Breakout team have really given me some invaluable experiences.
We build with visionary entrepreneurs who don't accept the status quo. The 10 years and $1B+ it takes to bring medicines from discovery to approval is unacceptable... and ready to be overhauled by computation.?? ? At our 2024 Magnify Debate, we tackled the question: ???? ????+???? ???????? ?????? ?????????????????? ???? ???????????? ?????????? ???????? ???? ?????? ???????? ?????????????????????? ??????????????, ?????????? ???????? ?????? ???????????? ???????????????????????? ???????????? ?????????? ??????????? ? Arguing for expanding the top of the funnel "Going Wide" David Younger of?A-Alpha Bio and?Karen Akinsanya of?Schr?dinger?championed expanding the search space to design molecules even nature hasn't seen. Fighting for improving success at the bottom of the funnel "Going Narrow" Ron Alfa, MD, PhD of?NOETIK and?Etai Jacob of?AstraZeneca explained how going deeper into underlying biology will improve translation to humans and deliver on the promises of precision medicine. So who won??Check the?highlight video and let us know your vote. PS - Interested in attending next year's event? Sign up for our newsletter to be the first to know:?https://lnkd.in/d3eRkTnG
-
We build with visionary entrepreneurs who don't accept the status quo. The 10 years and $1B+ it takes to bring medicines from discovery to approval is unacceptable... and ready to be overhauled by computation.?? ? At our 2024 Magnify Debate, we tackled the question: ???? ????+???? ???????? ?????? ?????????????????? ???? ???????????? ?????????? ???????? ???? ?????? ???????? ?????????????????????? ??????????????, ?????????? ???????? ?????? ???????????? ???????????????????????? ???????????? ?????????? ??????????? ? Arguing for expanding the top of the funnel "Going Wide" David Younger of?A-Alpha Bio and?Karen Akinsanya of?Schr?dinger?championed expanding the search space to design molecules even nature hasn't seen. Fighting for improving success at the bottom of the funnel "Going Narrow" Ron Alfa, MD, PhD of?NOETIK and?Etai Jacob of?AstraZeneca explained how going deeper into underlying biology will improve translation to humans and deliver on the promises of precision medicine. So who won??Check the?highlight video and let us know your vote. PS - Interested in attending next year's event? Sign up for our newsletter to be the first to know:?https://lnkd.in/d3eRkTnG
-
Congrats to Breakout Ventures Fellow Daniel Carbonero on his publication in Nature Scientific Reports! If you're into computation and neuroscience, this is your reading for the day!
I’m beyond proud to share that the foundation of my doctoral research - using machine learning to understand how neurons form and shift networks - has been published in Scientific Reports. This was certainly a labor of love, and I’m grateful to my co-author Jad Noueihed, PhD for all the day-to-day mentorship, and my co-advisors Mark Kramer and John White for making this all possible. Turning years of hard work into a cohesive story wasn’t easy. Looking beyond graduation this spring, I'm excited to dive deeper into the biotech sector to help get these types of technologies to where they are needed most. Always happy to chat with investors, founders, and industry builders! You can read the open-access publication here: https://lnkd.in/e6ryirBF TLDR: Neuronal network dynamics are integral to brain functions, enabling sensory encoding, motor control, memory, decision-making, and learning. While recording advances have enabled the collection of huge data sets, traditional downstream analysis cuts out almost all variant temporal activity. We used Nonnegative Matrix Factorization (NMF) to enhance the interpretability of large-scale data while still capturing the majority of its variant dynamics. Comfortably outperforming standard machine learning methods on both artificial and in vivo data, NMF can put neuro’s huge datasets to better use, paving the way for developing treatments for neurological disorders and designing brain-machine interfaces.
-
-
Congratulations to Daniel Carbonero, our Breakout Fellow at Boston University, on publishing his ML-driven neuroscience findings in Nature Scientific Reports!
I’m beyond proud to share that the foundation of my doctoral research - using machine learning to understand how neurons form and shift networks - has been published in Scientific Reports. This was certainly a labor of love, and I’m grateful to my co-author Jad Noueihed, PhD for all the day-to-day mentorship, and my co-advisors Mark Kramer and John White for making this all possible. Turning years of hard work into a cohesive story wasn’t easy. Looking beyond graduation this spring, I'm excited to dive deeper into the biotech sector to help get these types of technologies to where they are needed most. Always happy to chat with investors, founders, and industry builders! You can read the open-access publication here: https://lnkd.in/e6ryirBF TLDR: Neuronal network dynamics are integral to brain functions, enabling sensory encoding, motor control, memory, decision-making, and learning. While recording advances have enabled the collection of huge data sets, traditional downstream analysis cuts out almost all variant temporal activity. We used Nonnegative Matrix Factorization (NMF) to enhance the interpretability of large-scale data while still capturing the majority of its variant dynamics. Comfortably outperforming standard machine learning methods on both artificial and in vivo data, NMF can put neuro’s huge datasets to better use, paving the way for developing treatments for neurological disorders and designing brain-machine interfaces.
-
-
From soybeans to... leather? With new bio-based materials technology, companies like Modern Meadow are helping the fashion industry go green. ?????????? ???? ?? ????????????: ?? From bio-based faux leather to plant-based cashmere, soy materials are replacing petroleum-based inputs and animal fibers. ?? Modern Meadow is pioneering soy-derived materials through their Bio-Alloy green chemistry technology, including their Bio-Vera faux leather that is being used by top brands like TORY BURCH and Everlane. ?? Per Modern Meadow's general manager of biomaterials, Jeffrey Alan Smith, “A challenge faced by all new materials is the ability to reach an affordable scale quickly. We have been able to reach that scale quickly in part due to the existing scale of soy production today.” ???????? ?????? ???????? WWD ??????????????: https://lnkd.in/ewUsHRpQ
One Plant, Many Possibilities: Soy’s Growing Potential for Fashion?Production
wwd.com
-
Had a great time discussing the intersection of gene therapy and neuroscience with Matias Serebrinsky and Greg Kubin - check it out!
"Neuro is a very data-rich, insight-poor field... and those fields tend to really benefit from things like AI." ~Breakout Ventures' Partner Dana Watt, PhD on PsyMed Ventures' Business Trip podcast. ?????????? ???? ?? ????????????: ?? From Huntington’s to depression, gene and RNA-based therapies are unlocking new possibilities for treating brain and mental health disorders at their root cause. ?? Thanks to the power of advanced computation and AI, scientists can gain new insights into the complexity and diversity of psychiatric conditions down to the individual patient level. ? The bold question we're excited to uncover: Will neuro-focused therapies one day move from treatment to enhancement? ???????????? ???? ?????? ???????? Business Trip ?????????????? ???? PsyMed Ventures ???????? ?????????? Matias Serebrinsky ?????? Greg Kubin: https://lnkd.in/gWdJT3qR
-
"Neuro is a very data-rich, insight-poor field... and those fields tend to really benefit from things like AI." ~Breakout Ventures' Partner Dana Watt, PhD on PsyMed Ventures' Business Trip podcast. ?????????? ???? ?? ????????????: ?? From Huntington’s to depression, gene and RNA-based therapies are unlocking new possibilities for treating brain and mental health disorders at their root cause. ?? Thanks to the power of advanced computation and AI, scientists can gain new insights into the complexity and diversity of psychiatric conditions down to the individual patient level. ? The bold question we're excited to uncover: Will neuro-focused therapies one day move from treatment to enhancement? ???????????? ???? ?????? ???????? Business Trip ?????????????? ???? PsyMed Ventures ???????? ?????????? Matias Serebrinsky ?????? Greg Kubin: https://lnkd.in/gWdJT3qR